Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.06 g/t Au over 42 M and 1.36 g/t Au over 115.2 M (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prenetics Global Ltd PRE

Alternate Symbol(s):  PREJF

Healthcare
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool... see more

Recent & Breaking News (NDAQ:PRE)

Prenetics Announces Second Quarter 2024 Financial Results

GlobeNewswire 2 days ago

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

GlobeNewswire August 19, 2024

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham 

GlobeNewswire July 11, 2024

Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors

GlobeNewswire July 1, 2024

Prenetics Announces First Quarter 2024 Financial Results

GlobeNewswire June 18, 2024

Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

GlobeNewswire June 17, 2024

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire April 1, 2024

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

GlobeNewswire February 9, 2024

Prenetics Announces Third Quarter 2023 Financial Results

GlobeNewswire November 20, 2023

Prenetics Global Limited Announces Reverse Stock Split

GlobeNewswire November 1, 2023

Prenetics Announces Second Quarter 2023 Financial Results

GlobeNewswire September 15, 2023

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening

GlobeNewswire June 25, 2023

Prenetics Announces First Quarter 2023 Financial Results

GlobeNewswire June 5, 2023

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 14, 2023

Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology

GlobeNewswire March 2, 2023

Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire February 2, 2023

Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA

GlobeNewswire January 19, 2023

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

GlobeNewswire January 10, 2023

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

GlobeNewswire December 16, 2022

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

GlobeNewswire November 30, 2022
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested